Compare IQV & PRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IQV | PRU |
|---|---|---|
| Founded | 1982 | 1875 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Life Insurance |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4B | 41.2B |
| IPO Year | 2013 | N/A |
| Metric | IQV | PRU |
|---|---|---|
| Price | $243.25 | $118.38 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 11 |
| Target Price | ★ $240.60 | $118.60 |
| AVG Volume (30 Days) | 1.3M | ★ 1.5M |
| Earning Date | 02-05-2026 | 02-03-2026 |
| Dividend Yield | N/A | ★ 4.55% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 7.30 | 7.27 |
| Revenue | $15,904,000,000.00 | ★ $57,598,000,000.00 |
| Revenue This Year | $6.15 | N/A |
| Revenue Next Year | $5.39 | $2.81 |
| P/E Ratio | $33.30 | ★ $16.33 |
| Revenue Growth | ★ 3.85 | N/A |
| 52 Week Low | $134.65 | $90.38 |
| 52 Week High | $246.71 | $123.88 |
| Indicator | IQV | PRU |
|---|---|---|
| Relative Strength Index (RSI) | 72.42 | 67.36 |
| Support Level | $239.00 | $111.58 |
| Resistance Level | $246.71 | $119.76 |
| Average True Range (ATR) | 4.59 | 1.90 |
| MACD | 1.89 | 0.11 |
| Stochastic Oscillator | 86.01 | 83.13 |
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.
Prudential Financial is one of the largest US life insurers, offering annuities, life insurance, and asset-management products. The United States and Japan are its two largest markets. Its US business contributed about 50% of adjusted 2024 earnings and includes institutional retirement (mostly pension risk transfer), individual retirement (annuities), group insurance, and individual life insurance. Its international business represented about 40% of adjusted earnings, with a strong market position in Japan, and the firm also has a presence in emerging markets like Brazil. The company's investment management business, PGIM, contributed approximately 10% of its 2024 adjusted earnings. PGIM had around $1.4 trillion in assets under management at the end of third-quarter 2025.